Ceftaroline fosamil: a new broad-spectrum cephalosporin

FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia

(2011) Donald E. Low et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia

(2011) T. M. File et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Affinity of Ceftaroline and Other  -Lactams for Penicillin-Binding Proteins from Staphylococcus aureus and Streptococcus pneumoniae

(2010) K. Kosowska-Shick et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Effect of Ceftaroline on Normal Human Intestinal Microflora

(2010) G. Panagiotidis et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Activity of Ceftaroline against Community-Associated Methicillin-Resistant, Vancomycin-Intermediate, Vancomycin-Resistant, and Daptomycin-Nonsusceptible Staphylococcus aureus Isolates

(2010) L. Saravolatz et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Activity of Ceftaroline against Recent Emerging Serotypes of Streptococcus pneumoniae in the United States

(2010) M. R. Jacobs et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Integrated Analysis of CANVAS 1 and 2: Phase 3, Multicenter, Randomized, Double‐Blind Studies to Evaluate the Safety and Efficacy of Ceftaroline versus Vancomycin plus Aztreonam in Complicated Skin and Skin‐Structure Infection

(2010) G. Ralph Corey et al.   CLINICAL INFECTIOUS DISEASES

Integrated Analysis of FOCUS 1 and FOCUS 2: Randomized, Doubled‐Blinded, Multicenter Phase 3 Trials of the Efficacy and Safety of Ceftaroline Fosamil versus Ceftriaxone in Patients with Community‐Acquired Pneumonia

(2010) Thomas M. File et al.   CLINICAL INFECTIOUS DISEASES

Differences in the drug prescriptions to children by Italian paediatricians and general practitioners

(2010) Antonio Clavenna et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Antibiotic stewardship programmes--what's missing?

(2010) E. Charani et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections

(2010) M. H. Wilcox et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections

(2010) G. R. Corey et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Binding of ceftaroline to penicillin-binding proteins of Staphylococcus aureus and Streptococcus pneumoniae

(2010) H. Moisan et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Ceftaroline: A New Cephalosporin with Activity Against Resistant Gram-Positive Pathogens

(2010) Molly E Steed et al.   PHARMACOTHERAPY

In Vitro Activity of Ceftaroline Alone and in Combination against Clinical Isolates of Resistant Gram-Negative Pathogens, Including  -Lactamase-Producing Enterobacteriaceae and Pseudomonas aeruginosa

(2009) C. Vidaillac et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

POST-ANTIBIOTIC EFFECT OF CEFTAROLINE AGAINST GRAM-POSITIVE ORGANISMS

(2009) G. A. PANKUCH et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Molecular Basis and Phenotype of Methicillin Resistance in Staphylococcus aureus and Insights into New  -Lactams That Meet the Challenge

(2009) L. I. Llarrull et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Ten years of antibiotic consumption in ambulatory care: Trends in prescribing practice and antibiotic resistance in Austria

(2009) Sigrid Metz-Gercek et al.   BMC INFECTIOUS DISEASES

Trends in broad-spectrum antibiotic prescribing for children with acute otitis media in the United States, 1998–2004

(2009) Andrew S Coco et al.   BMC Pediatrics

Ceftaroline

(2009) George G. Zhanel et al.   DRUGS

Antibiotic prescribing over the last 16 years: fewer antibiotics but the spectrum is broadening

(2009) C. Llor et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Antibiotic Prescriptions for Upper Respiratory Tract Infection in Japan

(2009) Takahiro Higashi et al.   INTERNAL MEDICINE

Activity of the new cephalosporin ceftaroline against bacteraemia isolates from patients with community-acquired pneumonia

(2009) Ian Morrissey et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

In Vitro Evaluation of the Antimicrobial Activity of Ceftaroline against Cephalosporin-Resistant Isolates of Streptococcus pneumoniae

(2008) L. McGee et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Activity of Ceftaroline against Streptococcus pneumoniae Isolates Exhibiting Resistance to Penicillin, Amoxicillin, and Cefotaxime

(2008) A. Fenoll et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Antimicrobial Activity of a New Cephalosporin, Ceftaroline, and Determination of Quality Control Ranges for MIC Testing

(2008) S. D. Brown et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Profiling of Ceftaroline against a Collection of Recent Bacterial Clinical Isolates from across the United States

(2008) Y. Ge et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Co-opting the Cell Wall in Fighting Methicillin-ResistantStaphylococcus aureus: Potent Inhibition of PBP 2a by Two Anti-MRSA β-Lactam Antibiotics

(2008) Adriel Villegas-Estrada et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY